Where Did 2600 Come From? What It Teaches About Medical Device Cyber Risk

Understanding the Significance of 2600

“2600” is most closely tied to 2600 Hz, a tone that became famous in the early days of phone network hacking. Over time, “2600” turned into shorthand for a certain mindset: curiosity, hands-on learning, and the habit of looking at systems the way an attacker would.

For medical device manufacturers, the value isn’t the nostalgia. It’s the pattern behind it.

Complex systems usually fail at the edges. A “small” oversight, a forgotten interface, a default setting that made sense during development, can turn into an exploit path once the product is deployed in real clinical environments.

That’s why mature medical device cybersecurity programs don’t just focus on finding issues. They focus on ranking them consistently and fixing the right things first.

The 2600 in the Gaming Industry

A lot of people first saw “2600” on the Atari 2600, one of the most iconic early home consoles. It helped define an era of gaming and became a pop culture landmark.

At first glance, that has nothing to do with medical device security. But there’s a useful parallel: many early systems were built for performance and usability, not for hostile environments. Connected medical devices don’t have the luxury of that assumption anymore.

Today’s devices live on networks, talk to cloud services, rely on third-party components, and operate in environments where vulnerabilities get published and exploited. That reality makes disciplined prioritization essential, especially around third-party software, update mechanisms, exposed services, and vulnerability response.

The Phone Phreaking Connection

The original “2600” story traces back to phone phreaking. People discovered that specific tones could influence telephone switching systems, and 2600 Hz became a well-known example.

The modern takeaway is simple: many vulnerabilities aren’t magic tricks. Systems are often behaving “correctly” according to how they were designed. The problem is that designs don’t always hold up when someone uses the system in a way you didn’t anticipate.

In medical devices, we see the same thing when:

• a service interface exists because it helped manufacturing or field support
• a credential exists because it made troubleshooting easier
• a component shipped outdated because it worked and passed verification

None of that is unusual. What matters is how you identify the risk that creates, and how quickly you can prioritize and reduce it.

The 2600 Magazine and Its Influence

“2600” is also tied to 2600: The Hacker Quarterly, which helped shape hacker culture and security research by making “how systems really work” accessible to more people.

That mindset is valuable in MedTech. But regulated products also require something hacker culture didn’t historically emphasize: repeatability and documentation.

It’s not enough to say “we did security testing.” You need to be able to show:

• how you identify issues
• how you assess and rank them
• what you did about them
• and how you keep doing it after the device ships

This is where a strong vulnerability management process (and a defensible ranking method) becomes a competitive advantage, not just a checkbox.

Cultural Impact and Legacy

“2600” stuck around because it represents something bigger than one technical trick. It represents the habit of questioning assumptions, understanding systems deeply, and improving them.

For medical devices, that maps cleanly onto modern expectations: cybersecurity is part of product quality, and it directly affects patient safety, reliability, and regulatory readiness.

In practice, the companies that do this well tend to be the ones that treat the “boring” parts seriously: prioritization, patch planning, evidence collection, and postmarket response workflows.

What 2600 Teaches About Cybersecurity Risk Ranking in Medical Devices

This is the part many teams struggle with. Finding vulnerabilities isn’t usually the hard part. The hard part is deciding what matters most, what gets fixed first, and how to explain those decisions clearly.

A simple, practical way to approach medical device risk ranking looks like this:

Start with exploitability

How feasible is the attack in your real-world environment?

• Is the device network-accessible?
• Does it require authentication?
• Does it require user interaction?
• Is it complex or straightforward to exploit?

You can use a CVSS-style approach if it helps you stay consistent, but the real goal is to avoid “gut feel” rankings that change depending on who’s in the meeting.

Overlay clinical and patient impact

This is where medical devices differ from typical IT systems. Ask:

• Could therapy settings be changed?
• Could alarms be suppressed or delayed?
• Could availability be disrupted in a critical workflow?
• Could clinical decisions be influenced?

Factor in what’s happening in the real world

Threat intelligence matters. If something is actively exploited in the wild, it should usually jump the line.

Make the decision defensible

The best ranking decisions are the ones you can explain in plain language:

• why it matters for this device
• what mitigations exist right now
• what you’re doing next and when
• what the residual risk is and why it’s acceptable (or not)

That’s how you move from “we fixed what we could” to “we have a process that holds up under scrutiny.”

How Blue Goat Cyber Can Help

If your team needs help building a defensible cybersecurity risk ranking approach for FDA premarket submissions—or tightening postmarket vulnerability management—Blue Goat Cyber can help you turn cybersecurity work into clear, submission-ready evidence and processes your team can actually maintain.

Here are a few ways we help medical device teams:

• FDA Premarket Cybersecurity Services
• Medical Device Threat Modeling Services
• FDA-Compliant Vulnerability & Penetration Testing
• FDA-Compliant SBOM Services for MedTech
• FDA Postmarket Cybersecurity Services
• FDA Cybersecurity Deficiency Response
• Contact Blue Goat Cyber

FAQs

How should we rank vulnerabilities in a medical device?

Use a consistent method to score exploitability (many teams use a CVSS-style approach), then overlay clinical/patient impact and real-world signals like whether the issue is actively exploited. The key is having a repeatable rubric your engineering, QA/RA, and security teams can all explain and defend. If you want help building that rubric and the supporting documentation, start with our FDA premarket cybersecurity services.

Does the FDA require CVSS?

In practice, the FDA is most concerned that your approach is consistent, justified, and clearly tied to your device and its intended use. CVSS can help with consistency, but what matters is documenting your assumptions, your prioritization logic, and how you address cybersecurity risk across the product lifecycle. If you need verification evidence to support those decisions, our FDA-compliant penetration testing is designed to produce submission-ready output.

How does an SBOM help with risk ranking?

An SBOM helps you quickly identify whether you’re affected by newly disclosed vulnerabilities in third-party and open-source components. That speeds up triage, improves prioritization, and reduces the time between “new CVE announced” and “we know whether our device is exposed.” If you’re building an SBOM process that regulators and internal teams can rely on, see our FDA-compliant SBOM services.

Should we prioritize known-exploited vulnerabilities first?

Usually, yes. If a vulnerability is actively exploited in the wild, it should jump ahead of theoretical issues—especially when the device is network-accessible, deployed broadly, or used in high-impact clinical workflows. The best approach is to combine exploitation signals with your clinical impact overlay and your threat model, then document the resulting decision.

What evidence should we keep to justify prioritization decisions?

Keep enough detail that someone outside your team can follow the logic: your scoring method, threat model assumptions, test results, mitigations/remediation plan, verification evidence, and the rationale for any residual risk you accept. This becomes even more important postmarket. If you want a programmatic approach, our postmarket cybersecurity services are built around intake, triage, action, and documentation.

Conclusion

So where did 2600 come from? It grew out of a mix of technical history and culture: phone phreaking, hacker curiosity, and communities built around understanding how systems behave.

For medical device manufacturers, the practical takeaway is modern: small weaknesses can create big consequences, so vulnerability ranking, prioritization, and lifecycle cybersecurity management matter. If you want help turning that into a repeatable, submission-ready process, talk to Blue Goat Cyber.